DCs are key immune cells involved in severe COVID-19-induced lung damage mediated by aldosterone, which can stimulate DCs to produce IL-6 and transforming growth factor-β1 via the mineralocorticoid receptor (Figure 1) (63, 64). This evidence concerns the gene IL6 and COVID-19.